Lawyer Resources for Medical Device Failures

Unfortunately, defective products causing injury to elderly patients is not uncommon. This can lead to prolonged periods of recovery and high medical expenses. However, it is important to know the difference between injuries that are the result of defective products and injuries that occur because of product misuse. The first falls under product liability – a specific area of the law that holds companies responsible for any injury that is the result of a product they sell, distribute, create, or design.

What are defective products?

The definition is commercially produced goods unfit for intended use. They may lack sufficient instructions for using the product safely or pose dangers that are not immediately obvious. The three different types of defects include marketing, manufacturing, and design. An incorrect design may mean the product does not achieve its intended goal. Even if the design is flawless, if it is poorly manufactured it may lead to problems. Finally, not warning patients about possible dangers that may occur while using the item is a marketing defect.

What types of products and medical devices lead to problems with the elderly?

Four distinct categories commonly lead to issues with elderly users. Some of these products are less likely to cause issues in nursing homes than others are.

Consumer goods – There are some consumer goods that are safe for younger users, but may be dangerous for elderly users because they have reduced reaction times and decreased strength. Examples include kitchen appliances, furniture, and bath equipment.
Medical implants – Stents or artificial hips may wear out prematurely or malfunction. A good example of this would be the recall of DePuy artificial hips. In total, almost 100,000 people were affected because of this recall. Similarly, the recall of the Stryker Rejuvenate ABG II hips.
Medical equipment – Medical or durable medical equipment (DME) such as hospital beds, walkers, and wheelchairs may be very difficult to use. This means it is easy for the user to hurt him or herself without the proper training or instructions.
Defective prescription drugs – Sometimes prescription drugs are used to treat one medical condition, but have such dramatic side effects that they lead to other problems. Examples here could include heart attacks because of diabetes medication.

Why this is devastating for the elderly

Many elderly patients are unable to recover fully after a serious issue with defective products. This brings additional physical pain and mental anguish along with it, and often leads to increased medical bills.

It is true that the manufacturer plays an important role here, but the nursing home also needs to play its part. Especially when providing certain items for their residents, these nursing homes have a duty to purchase their products from reputable manufacturers. If you believe that defective products are causing problems for you or someone close to you, remember that legal action is not always about money. It can be about holding those people who are acting negligently responsible to make sure that others never have to deal with the same problems again.

Lawyers with experience handling your particular type of medical device recall case

What distinguished Rosenfeld Injury Lawyers from other law firms handling medical device and drug recalls is that we focus on several areas exclusively. This level of focus allows us to concentrate our resources into specific cases to achieve superior results for our clients. Before you talk to a general ‘product liability law firm’ that you may have seen on television, give our office a call and talk with an attorney who has experience handling cases like yours.

May 16, 2013

Dangers Related To Byetta And Januvia Not New

by Nursing Home Law Center Staff

Although the latest warning from the FDA regarding drugs like Byetta and Januvia only came in March 2013, the dangers have been known for many years. The recent information released by the FDA that researchers have found pre-cancerous cells in deceased patients using the drugs came after several previous warnings dating back to 2007. Although the FDA has yet to confirm the link between these drugs and pancreatic cancer, many believe that it is only a matter of time.

Bad News From The Beginning

Byetta still had that new-drug smell when reports began trickling in that patients using the drug were having a higher incidence of pancreatitis. The FDA approved Byetta in 2005 and by 2007, the first FDA alert was issued that patients using the drug had reported to the FDA that they had pancreatitis. The next year, another alert was issued, with reports of patients dying from the disease.

April 3, 2013

Fresenius Suspected Of Not Warning Dialysis Patients Of Heart Risk

by Nursing Home Law Center Staff

Fresenius Medical Care, a German-based company, is the largest provider of dialysis services and products in the U.S., providing dialysis to over a third of the patients in need of the treatment. The FDA is looking into allegations that the company knowingly failed to notify patients of a possible heart risk with the use of their products, GranuFlo and Naturalyte. The company issued a warning about the product to consumers in late March 2012 and a Class 1 recall was issued but this only occurred after internal sources within the company leaked a memo to the FDA that indicates that the company knew of the problem months earlier.

FDA Investigation

The internal memo that was leaked to the FDA was written in November 2011, over four months before the recall of the products in the end of March 2012. The memo was addressed to physicians within the organization’s dialysis centers, stating that improper use of one of their products was attributing to an increased risk of cardiac arrest in their patients. In fact, 941 patients had a cardiac arrest episode within their centers in 2010. However, they did not warn any other dialysis centers or doctors externally that use their product of the increased risk of heart problems to their patients.

March 25, 2013

Lawsuits Mounting Against Stryker Related To Its Defective Hips

by Nursing Home Law Center Staff

A growing number of lawsuits have been filed against Stryker Corporation related to its defective hips. One of the more recent Stryker Rejuvenate lawsuits involves a man from Georgia who required a revision surgery less than one-year after he developed complications following his original hip replacement. The lawsuit alleges that the defective design of the Stryker Rejuvenate product resulted in complications such as:

Pseudo-tumors
Fretting and corrosion of the metal used in the device

January 29, 2013

How Much Are DePuy ASR Cases Really Worth?

by Nursing Home Law Center Staff

All civil lawsuits come down to one thing— money. Sure, there will always be people who claim that they have filed their lawsuit out of a a sense of social responsibility and a genuine desire to help mankind, but injury cases– and medical device cases in particular– are really about getting financial compensation for an injury.

As soon as the DePuy ASR hip prosthesis was pulled from the market in August, 2010, a stream of people with these defective metal hip implants filed lawsuits against the manufacturer alleging amongst several things that the device resulted in pain, disability which may had resulted in the need for additional medical care or perhaps prevented a person from going about their employment.

Status of the current lawsuits

December 24, 2012

Signs and Symptoms of Hip Implant Failure or Injury

by Nursing Home Law Center Staff

With all the medical advances that are made year after year, some you would never expect. The fact that the majority of hip implants being used today (and over the last decade) have high failure rates and risk of injury is simply unacceptable. While many manufacturers of these dangerous products have recalled their faulty hip implants, many are still suffering the consequences.

Manufacturers of medical devices have an obligation to provide patients with a safe device. When they recognize that there are any defects or hazards associated with their product they must promptly respond to and rectify the situation by alerting patients, doctors, and the proper government agencies.

Recognizing the Signs Of Hip Failure

May 2, 2012

British Medical Journal: DePuy Knew About Faulty Hip Implants as Long as 7 Years Ago, Even Though Product Was Only Recalled in 2010

by Nursing Home Law Center Staff

A scathing report issued by the British Medical Journal (BMJ) says DePuy Orthopaedics was well aware that several of its hip implants were faulty, even as it continued to aggressively market the products to surgeons.

The report, written by BMJ investigations editor Deborah Cohen, cites an internal DePuy memo from 2005. The memo reads:

“In addition to inducing potential changes in immune function, there has been concern for some time that wear debris may be carcinogenic. The mechanism is not known and only 24 local malignancies have been reported in patients with joint replacements. Also worrying is the possibility of distant effect. One study suggested a threefold risk of lymphoma and leukemia 10 years after joint replacement.”

April 9, 2012

Video Interview: Discussing the DePuy Hip Replacement Recall with LXBN TV

by Nursing Home Law Center Staff

As I wrote about yesterday, the latest developments in the DePuy hip implant recall reveal the company was putting profits before patient well-being by continuing to allow the hips to be implanted despite knowledge of numerous problems with the devices. In an interview recorded earlier today with LXBN TV, I discuss that and the background of the recall with Colin O’Keefe.

April 4, 2012

Recent Disclosures Reinforce DePuy’s Intent To Put Corporate Profits Ahead Of Patient Safety

by Nursing Home Law Center Staff

It seems like the more we learn about the inner workings at the corporate offices of DePuy, the well known manufacturer of artificial hips and a subsidiary of Johnson & Johnson, the more disturbing image we have about a company that clearly puts its bottom line ahead of everything else— even patient safety.

A recent New York Times article, “Hip Device Phaseout Followed F.D.A, Data Request” depicts a company so focused on corporate profitability that the company continued to allow their artificial hips to be implanted in patients after mounting data suggested problems with the devices including: premature failure, metal poisoning and other disabilities in patients.

The Times article cites a 2009 letter from the FDA to executives at DePuy highlighting concerns about the manufacturer’s ASR hip implant devices lackluster track record for safety. In contrast to a safe hip replacement device that was promoted to last an anticipated 15 years in patients, the FDA letter voiced concerns over the devices longevity and metal-on-metal design that seemed to correlate with a higher than anticipated failure rate.

November 21, 2011

All-Metal Hip Resurfacing Devices Receive More Scrutiny

by Nursing Home Law Center Staff

Following the well-publicized troubles associated with all-metal hip replacement devices manufactured by DePuy and others, a recent study casts concerns about a similar hip surgery known as “hip resurfacing”.

The New York Times reported on a study study conducted by the California Technology Assessment Forum, found that the metal hip resurfacing devices had higher premature failure rates than expected and exposed patients to potential health problems when the metal debris from the devices splintered off from wear than initially expected.

Hip resurfacing procedures have been embraced by the medical community as a less invasive procedure compared with a complete hip replacement as the resurfacing procedures can preserve more of the patient’s bone and a perceived shorter recovery time.

Bad News From The Beginning

FDA Investigation

Status of the current lawsuits

Recognizing the Signs Of Hip Failure

Client Reviews